Cabaletta Bio, Inc.
CABA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $345 | $468 | $485 | $468 |
| Gross Profit | -$345 | -$468 | -$485 | -$468 |
| % Margin | – | – | – | – |
| R&D Expenses | $39,824 | $37,638 | $29,018 | $25,532 |
| G&A Expenses | $6,764 | $0 | $0 | $0 |
| SG&A Expenses | $6,764 | $7,800 | $7,633 | $7,785 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$345 | $0 | $0 | $0 |
| Operating Expenses | $46,243 | $45,438 | $36,651 | $33,317 |
| Operating Income | -$46,588 | -$45,906 | -$37,136 | -$33,785 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,722 | $778 | $1,193 | $1,199 |
| Pre-Tax Income | -$44,866 | -$45,128 | -$35,943 | -$32,586 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$44,866 | -$45,128 | -$35,943 | -$32,586 |
| % Margin | – | – | – | – |
| EPS | -0.44 | -0.73 | -0.73 | -0.65 |
| % Growth | 39.7% | 0% | -12.3% | – |
| EPS Diluted | -0.44 | -0.73 | -0.73 | -0.65 |
| Weighted Avg Shares Out | 102,263 | 61,877 | 49,524 | 50,132 |
| Weighted Avg Shares Out Dil | 102,263 | 61,877 | 49,471 | 50,198 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,808 | $1,410 | $1,487 | $1,947 |
| Interest Expense | $584 | $571 | $294 | $748 |
| Depreciation & Amortization | $345 | $468 | $485 | $468 |
| EBITDA | -$43,937 | -$44,089 | -$35,164 | -$31,370 |
| % Margin | – | – | – | – |